Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients

Johanna H. M. Driessen; Hein A. van Onzenoort; Arief Lalmohamed; Corinne Klop; Marloes Bazelier; Kees Neef; Frank de Vries

Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients

Johanna H. M. Driessen, Hein A. van Onzenoort, Arief Lalmohamed, Corinne Klop, Marloes Bazelier, Kees Neef, Frank de Vries

Clinical Pharmacy

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Pages (from-to)	513-513
Number of pages	1
Journal	Pharmacoepidemiology and Drug Safety
Volume	22
Publication status	Published - Oct 2013

Cite this

@article{a0a944f8496746df933d81d610139c61,

title = "Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients",

author = "Driessen, {Johanna H. M.} and {van Onzenoort}, {Hein A.} and Arief Lalmohamed and Corinne Klop and Marloes Bazelier and Kees Neef and {de Vries}, Frank",

year = "2013",

month = oct,

language = "English",

volume = "22",

pages = "513--513",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients

AU - Driessen, Johanna H. M.

AU - van Onzenoort, Hein A.

AU - Lalmohamed, Arief

AU - Klop, Corinne

AU - Bazelier, Marloes

AU - Neef, Kees

AU - de Vries, Frank

PY - 2013/10

Y1 - 2013/10

M3 - Meeting Abstract

SN - 1053-8569

VL - 22

SP - 513

EP - 513

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

ER -